Alembic Pharmaceuticals' JV gets USFDA final nod for anti-fungal drug

The approval by the US Food & Drug Administration (USFDA) is for the abbreviated new drug application (ANDA) for Nystatin and Triamcinolone Acetonide Ointment of strength 100,000 units/gram, Alembic Pharmaceuticals said in a regulatory filing.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/xsHV4uM
via IFTTT